The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
The Met Office is maintaining a severe weather warning in parts of eastern England through Tuesday and into Wednesday.
Blur frontman Damon Albarn and The Lewisham and Greenwich NHS Choir have been added to the final Glastonbury line-up.
Amber Heard's lawyers said her decision not to give an initial police statement has been used against her by Johnny Depp's legal team.